BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 37720544)

  • 1. Unraveling the impact of disrupted nucleocytoplasmic transport systems in
    McGoldrick P; Robertson J
    Front Cell Neurosci; 2023; 17():1247297. PubMed ID: 37720544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
    Zhang K; Grima JC; Rothstein JD; Lloyd TE
    Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.
    Sattler R; Traynor BJ; Robertson J; Van Den Bosch L; Barmada SJ; Svendsen CN; Disney MD; Gendron TF; Wong PC; Turner MR; Boxer A; Babu S; Benatar M; Kurnellas M; Rohrer JD; Donnelly CJ; Bustos LM; Van Keuren-Jensen K; Dacks PA; Sabbagh MN;
    Neurol Ther; 2023 Dec; 12(6):1821-1843. PubMed ID: 37847372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
    Beckers J; Tharkeshwar AK; Van Damme P
    Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
    Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
    Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.
    Zhang K; Daigle JG; Cunningham KM; Coyne AN; Ruan K; Grima JC; Bowen KE; Wadhwa H; Yang P; Rigo F; Taylor JP; Gitler AD; Rothstein JD; Lloyd TE
    Cell; 2018 May; 173(4):958-971.e17. PubMed ID: 29628143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.
    Fallini C; Khalil B; Smith CL; Rossoll W
    Neurobiol Dis; 2020 Jul; 140():104835. PubMed ID: 32179176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Immune Activation by
    Trageser KJ; Smith C; Herman FJ; Ono K; Pasinetti GM
    Front Neurosci; 2019; 13():1298. PubMed ID: 31920478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
    Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
    Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Small Molecules Rescue Nucleocytoplasmic Transport and DNA Damage Phenotypes in C9ORF72 ALS/FTD.
    Ramic M; Andrade NS; Rybin MJ; Esanov R; Wahlestedt C; Benatar M; Zeier Z
    Brain Sci; 2021 Nov; 11(11):. PubMed ID: 34827542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS.
    Coyne AN; Baskerville V; Zaepfel BL; Dickson DW; Rigo F; Bennett F; Lusk CP; Rothstein JD
    Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321318
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kortazar-Zubizarreta I; Manero-Azua A; Afonso-Agüera J; Perez de Nanclares G
    J Pers Med; 2023 Sep; 13(9):. PubMed ID: 37763163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
    Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
    Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p.
    Stewart H; Rutherford NJ; Briemberg H; Krieger C; Cashman N; Fabros M; Baker M; Fok A; DeJesus-Hernandez M; Eisen A; Rademakers R; Mackenzie IR
    Acta Neuropathol; 2012 Mar; 123(3):409-17. PubMed ID: 22228244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion.
    Fong JC; Karydas AM; Goldman JS
    Alzheimers Res Ther; 2012; 4(4):27. PubMed ID: 22808918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.